SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026737
Filing Date
2021-05-12
Accepted
2021-05-12 07:39:51
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-10q_20210331.htm 10-Q 1207134
2 EX-31.1 cogt-ex311_10.htm EX-31.1 9993
3 EX-31.2 cogt-ex312_7.htm EX-31.2 9964
4 EX-32.1 cogt-ex321_6.htm EX-32.1 5975
5 EX-32.2 cogt-ex322_8.htm EX-32.2 5935
  Complete submission text file 0001564590-21-026737.txt   4669496

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cogt-20210331.xml EX-101.INS 798977
7 XBRL TAXONOMY EXTENSION SCHEMA cogt-20210331.xsd EX-101.SCH 45627
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20210331_cal.xml EX-101.CAL 38996
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20210331_def.xml EX-101.DEF 172270
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20210331_lab.xml EX-101.LAB 357804
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20210331_pre.xml EX-101.PRE 270619
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 21913472
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences